13D/A filed by ARCH Venture Fund XII, L.P.
ARCH Venture Fund XII, L.P. and 11 other reporting persons reported 18,642,036 PRME shares, 8.4% of the class, as of 2026-11-12, in a 13D/A accepted by EDGAR 2026-11-13 21:05:02 UTC.
- Accession
- 0001193125-26-460600
- Filer
- CIK 1906837
- Filed
- 2026-11-13
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Stake
- Subject
- PRME · Prime Medicine, Inc.
- Shares
- 18,642,036
- Percent of class
- 8.4%
- Event date
- 2026-11-12
How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.
Read for the filer group ARCH Venture Partners XII, LLC.
Reporting persons
| Person | Type | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Aggregate | Percent |
|---|---|---|---|---|---|---|---|
| ARCH Venture Fund X, L.P. | PN | 0 | 18,486,894 | 0 | 18,486,894 | 18,486,894 | 8.3% |
| ARCH Venture Fund X Overage, L.P. | PN | 0 | 18,486,894 | 0 | 18,486,894 | 18,486,894 | 8.3% |
| ARCH Venture Fund XII, L.P. | PN | 0 | 18,486,894 | 0 | 18,486,894 | 18,486,894 | 8.3% |
| ARCH Venture Partners X, L.P. | PN | 0 | 18,486,894 | 0 | 18,486,894 | 18,486,894 | 8.3% |
| ARCH Venture Partners X Overage, L.P. | PN | 0 | 18,486,894 | 0 | 18,486,894 | 18,486,894 | 8.3% |
| ARCH Venture Partners XII, L.P. | PN | 0 | 18,486,894 | 0 | 18,486,894 | 18,486,894 | 8.3% |
| ARCH Venture Partners X, LLC | OO | 0 | 18,486,894 | 0 | 18,486,894 | 18,486,894 | 8.3% |
| ARCH Venture Partners XII, LLC | OO | 0 | 18,486,894 | 0 | 18,486,894 | 18,486,894 | 8.3% |
| Robert Nelsen | IN | 155,142 | 18,486,894 | 155,142 | 18,486,894 | 18,642,036 | 8.4% |
| Keith Crandell | IN | 0 | 18,486,894 | 0 | 18,486,894 | 18,486,894 | 8.3% |
| Kristina Burow | IN | 0 | 18,486,894 | 0 | 18,486,894 | 18,486,894 | 8.3% |
| Steven Gillis | IN | 0 | 18,486,894 | 0 | 18,486,894 | 18,486,894 | 8.3% |